维普期刊资源整合服务平台（V6.5）

86篇 您的检索式：期刊名="Chn Oncol"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	randomized trial of neoadjuvant cisplatin,vincristine,bleomyin,and radical hysterectomy versus radiation therapy for bulky stage I B and II A cervical cancer 显示文摘	Chang TC Lai CH Hong JH	2000	Chn Oncol2000，18，8：	1
2	Efficacy and safety of rasburicase(recombinant urate oxidase)for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma:research of the GRAALI(group d'etude des lymphomas de I 'adult trial on rasburicase activity in adult lymphoma)Study显示文摘	Coiffier B Mounier N Bologna S	2003	J CHn Oncol2003，21，23：	1
3	Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results显示文摘	R6del C Grabenbauer GG K/ihn R	2002	J Chn Oncol2002，20，14：	1
4	The biology and clinical relevance of the PTEN tumor suppressor pathway显示文摘	Sansal I Sellers WR	2004	Chn Oncol2004，22，：	1
5	Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin(THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma:the THP Monotherapy Study Group Trial显示文摘	Ito A Shintaku I Satoh M	2013	J Chn Oncol2013，31，11：	1
6	Methodological and practical challenges for personalized cancer therapies 显示文摘	Wistuba II Gelovani JG Jacoby JJ	2011	Nat Rev Chn Oncol2011，8，3：	1
7	Individualfluorouracil dose adjustment based onpharmacokinetic follow-up compared withconventional dosage: results of a multicenterrandomized trial of patients with metastaticcolorectal cancer显示文摘	GAMELIN E DELVA R JACOB J	2008	J CHn Oncol2008，26，13：	1
8	Phase Ⅱ evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or prim ary peritoneal carcinoma:a study of the Gynecologic Oncology Group显示文摘	Miller DS Blessing JA Krasner CN	2013	T Chn Oncol2013，27，16：	1
9	KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience显示文摘	Bokemeyer C Bondarenko I Hartmann JT	2008	J Chn Oncol2008，26，：	1
10	Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, pachtaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor recptor 2-positive operable breast cancer 显示文摘	Buzdar AU Ibrahim NK Francis D	2005	Chn Oncol2005，23，16：	1
11	Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy 显示文摘	Coiffier B Pro B Prince HM	2012	J Chn Oncol2012，30，6：	1
12	Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion injury显示文摘	VINTEN-JO HANSEN J JIANG R REEVES JG	2007	Hematol Oncol Chn North Am2007，21，1：	1
13	CD10 - positive stro- real cells in gastric carcinoma: correlation with invasion and metastasis显示文摘	Huang WB Zhou XJ Chen JX	2005	Jpn J Chn Oncol2005，35，5：	1
14	Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic reevaluation of clinical evidence and drug cost implications显示文摘	Geling O Eichler HG	2005	J Chn Oncol2005，23，6：	1
15	Phase Ⅱ trial of paclitaxel in patients with progressive ovarian carcinoma after platium-based chemotherapy: a gynecologic oncology group study显示文摘	Thigpen J T Blessing J A Ball H	2001	J Chn Oncol2001，12，5：	1
16	Efficacy of neoadjuvant cisplatin in triple-negative breast cancer 显示文摘	SILVER D P RICHARDSON A L EKLUND A C	2010	J Chn Oncol2010，28，7：	1
17	High expression of microma- 210 is an independent factor indicating a poor prognosis in japa- nese triple-negative breast cancer patients 显示文摘	Toyama T Kondo N Endo Y	2012	Jpn J Chn Oncol2012，42，4：	1
18	Definitive results of a phase iii adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: THE NSABP B-38 trial显示文摘	Swain SM Taag G Geyer CE el al	2013	J Chn Oncol2013，31，26：	1
19	Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab 显示文摘	Khambata-Ford S Garrett CR Meropol N J	2007	J Chn Oncol2007，25，22：	1
20	Peripheral neuropathy induced by microtubule- stabilizing agents显示文摘	Lee J J Swain SM	2006	J Chn Oncol2006，24，10：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示